© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent


Stamp duty holiday for IPOs still leaves UK with one of highest taxes on trading
Country’s IPO market is returning after lull caused by political instability
◆ Why Europe's corporate bond market is on a roll ◆ Reverse Yankees, hot hybrids and huge size with more to come ◆ Europe's stock exchanges' attempts to drum up more IPOs
Hope SIU could boost retail investment flows
More articles/Ad

More articles/Ad

More articles

  • Swedish fintech company Nordnet is preparing to test investor sentiment towards European IPOs following the US election, having announced its intention to float on Nasdaq Stockholm.
  • Chinese property manager Jinke Smart Services Group has launched its IPO. It is aiming to pocket up to HK$6.3bn ($815.9m) from the deal.
  • China’s decision to clamp down on Ant Group has derailed an IPO of at least $34bn, despite execution being finished last week. The move appears to be little more than political muscle-flexing by Beijing. The real winners will be the country’s critics.
  • Global equity markets have reversed earlier losses after former US vice-president Joe Biden gained momentum in the presidential race on Wednesday afternoon, giving capital markets bankers hope that a decisive result this week might be possible.
  • Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.
  • Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.